Infographic: Consensus Recommendations on Biosimilars in Rheumatology

An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars to treat rheumatologic diseases. Learn more about what the panel had to say.

An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars to treat rheumatologic diseases. Learn more about what the panel had to say.

Related Content:

PracticeBusinessPolicy
Can Global Policies to Boost Biosimilar Adoption Work in the US?
Breaking Down Biosimilar Barriers: Interchangeability
Breaking Down Biosimilar Barriers: Payer and PBM Policies